EYEPOINT PHARMACEUTICALS INC's ticker is EYPT and the CUSIP is 30233G209. A total of 93 filers reported holding EYEPOINT PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.39 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $857,000 | -44.9% | 108,285 | -45.2% | 0.29% | -39.5% |
| Q2 2022 | $1,555,000 | -31.1% | 197,640 | +6.4% | 0.48% | -48.7% |
| Q1 2022 | $2,256,000 | +1.3% | 185,666 | +2.1% | 0.93% | +3.5% |
| Q4 2021 | $2,226,000 | +65.3% | 181,886 | +40.7% | 0.90% | +18.4% |
| Q3 2021 | $1,347,000 | -38.2% | 129,290 | -46.6% | 0.76% | -21.5% |
| Q2 2021 | $2,178,000 | -28.5% | 242,309 | -19.2% | 0.97% | -41.6% |
| Q1 2021 | $3,048,000 | – | 300,000 | – | 1.66% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Essex Woodlands Management, Inc. | 3,490,921 | $27,892,459 | 24.59% |
| ACUTA CAPITAL PARTNERS, LLC | 300,128 | $2,398,023 | 1.61% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 3,492,147 | $27,902,255 | 1.51% |
| Cormorant Asset Management, LP | 3,200,000 | $25,568,000 | 1.49% |
| Samsara BioCapital, LLC | 432,000 | $3,451,680 | 1.06% |
| Ghost Tree Capital, LLC | 325,000 | $2,596,750 | 0.85% |
| RA Capital Management | 3,370,506 | $26,930,343 | 0.53% |
| Ikarian Capital, LLC | 4,487 | $3,585,113 | 0.43% |
| Affinity Asset Advisors, LLC | 155,000 | $1,238,450 | 0.35% |
| SECTORAL ASSET MANAGEMENT INC | 176,080 | $1,406,879 | 0.27% |